Adial Pharmaceuticals Targets $40B Addiction Market
Adial Pharmaceuticals acquires patent for genetic diagnostic tool to identify patients who may respond well to their lead drug AD04, ...
- Latest
- Trending
Adial Pharmaceuticals acquires patent for genetic diagnostic tool to identify patients who may respond well to their lead drug AD04, ...
U.S. stocks plunged as inflation data dashed hopes of rate cuts, causing a sharp decline. High-growth sectors and smaller firms ...
Gates Industrial Corporation plc has announced the pricing of a secondary offering of 17.5 million ordinary shares, with a share ...
Allegro MicroSystems, a global leader in power and sensing semiconductor solutions, will present at Morgan Stanley's conference. This signals their ...
Ecolab reported strong Q4 sales growth driven by increased prices and new business opportunities in its institutional and specialty division. ...
Princeton-based fusion energy company, Thea Energy, has raised $20 million in Series A funding to advance its fusion technology and ...
Chinese space startups are racing to catch up with SpaceX by reducing costs and developing reusable rockets. Private companies aim ...
A1 Telekom Austria, Nokia, and Microsoft have successfully trialed the delivery of secure enterprise cloud applications on mobile devices using ...
Thyssenkrupp is set to report Q1 results with a projected drop in revenue and profit. Investors are eagerly awaiting updates ...
Telecom giants Nokia and A1 have conducted the first-ever 5G edge cloud network slicing trial in the media industry. This ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.